Citadel Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-57,801
| Closed | -$580K | – | 7058 |
|
|
2023
Q4 | $580K | Buy |
+57,801
| New | +$580K | ﹤0.01% | 3582 |
|
|
2022
Q2 | – | Sell |
-54,383
| Closed | -$126K | – | 7177 |
|
|
2022
Q1 | $126K | Buy |
+54,383
| New | +$126K | ﹤0.01% | 5530 |
|
|
2021
Q4 | – | Sell |
-17,514
| Closed | -$243K | – | 7412 |
|
|
2021
Q3 | $243K | Sell |
17,514
-22,948
| -57% | -$318K | ﹤0.01% | 5215 |
|
|
2021
Q2 | $526K | Buy |
40,462
+1,763
| +5% | +$22.9K | ﹤0.01% | 4667 |
|
|
2021
Q1 | $596K | Buy |
+38,699
| New | +$596K | ﹤0.01% | 4426 |
|